We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-5.09%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$745M
AUM Growth
-$51.2M
Cap. Flow
-$4.97M
Cap. Flow %
-0.67%
Top 10 Hldgs %
3.53%
Holding
1,995
New
631
Increased
376
Reduced
341
Closed
636

Top Buys

Rank Stock Value
1
KOD icon
Kodiak Sciences
KOD
+$3.17M
2
CSTM icon
Constellium
CSTM
+$2.67M
3
KTB icon
Kontoor Brands
KTB
+$2.5M
4
SMTC icon
Semtech
SMTC
+$2.34M
5
CXT icon
Crane NXT
CXT
+$2.34M

Sector Composition

Rank Sector Weight
1 Healthcare 16.38%
2 Industrials 16.37%
3 Technology 14.13%
4 Consumer Discretionary 10.96%
5 Financials 10.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEWR
1101
DELISTED
New Relic, Inc.
NEWR
$226K 0.03%
+3,383
New +$277K
FOE
1102
DELISTED
Ferro Corporation
FOE
$226K 0.03%
+10,384
New +$226K
OSK icon
1103
Oshkosh
OSK
$9.59B
$225K 0.03%
2,232
-223
-9% -$25.1K
SPRO icon
1104
Spero Therapeutics
SPRO
$73M
$225K 0.03%
+25,916
New +$266K
CEVA icon
1105
CEVA Inc
CEVA
$1.08B
$224K 0.03%
+5,514
New +$214K
NRIX icon
1106
Nurix Therapeutics
NRIX
$2.65B
$224K 0.03%
+15,963
New +$283K
CFB
1107
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$224K 0.03%
+14,222
New +$225K
BG icon
1108
Bunge Global
BG
$20.8B
$223K 0.03%
+2,008
New +$206K
DNLI icon
1109
Denali Therapeutics
DNLI
$3.97B
$223K 0.03%
6,940
+1,106
+19% +$38.1K
DXC icon
1110
DXC Technology
DXC
$1.73B
$223K 0.03%
+6,847
New +$226K
FLIC
1111
DELISTED
First of Long Island Corp
FLIC
$223K 0.03%
+11,483
New +$247K
JCI icon
1112
Johnson Controls International
JCI
$92.2B
$223K 0.03%
3,398
-7,425
-69% -$511K
NKE icon
1113
Nike
NKE
$61.9B
$223K 0.03%
+1,657
New +$233K
YETI icon
1114
Yeti Holdings
YETI
$3.95B
$223K 0.03%
+3,717
New +$240K
RHI icon
1115
Robert Half
RHI
$4.37B
$222K 0.03%
+1,943
New +$224K
QUOT
1116
DELISTED
Quotient Technology Inc
QUOT
$221K 0.03%
+34,629
New +$232K
DLR icon
1117
Digital Realty Trust
DLR
$71.7B
$220K 0.03%
+1,550
New +$224K
GFS icon
1118
GlobalFoundries
GFS
$29.6B
$220K 0.03%
+3,517
New +$207K
XRN
1119
Chiron Real Estate Inc
XRN
$477M
$220K 0.03%
+2,693
New +$220K
ICHR icon
1120
Ichor Holdings
ICHR
$2.56B
$220K 0.03%
6,185
+739
+14% +$28.8K
JBGS
1121
JBG SMITH
JBGS
$708M
$220K 0.03%
7,516
-1,371
-15% -$38.6K
ARCO icon
1122
Arcos Dorados Holdings
ARCO
$1.74B
$219K 0.03%
26,983
-169,278
-86% -$1.17M
KBH icon
1123
KB Home
KBH
$3.59B
$219K 0.03%
+6,750
New +$266K
MBIN icon
1124
Merchants Bancorp
MBIN
$2.49B
$219K 0.03%
+8,000
New +$238K
VIRT icon
1125
Virtu Financial
VIRT
$4.93B
$219K 0.03%
+5,876
New +$194K

Similar funds

GSA Capital Partners's Q1 2022 Portfolio in Review

As of Q1 2022, GSA Capital Partners held 1,995 positions worth $745M, down 6.4% from $796M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

GSA Capital Partners's Q1 2022 filing shows 631 new, 376 increased, 341 reduced and 636 closed positions. Its largest new stake was Kodiak Sciences: 81,285 shares worth $628K. The largest sale was State Street Consumer Staples Select Sector SPDR ETF, an estimated $2.96M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Industrials and Technology.

  • GSA Capital Partners's largest Q1 2022 buy was Kodiak Sciences: 81,285 shares worth $628K.
  • GSA Capital Partners added most to UMB Financial in Q1 2022, an estimated $1.88M increase.
  • GSA Capital Partners's biggest Q1 2022 reduction was Cleveland-Cliffs, cutting an estimated $2.09M.
  • GSA Capital Partners fully exited State Street Consumer Staples Select Sector SPDR ETF in Q1 2022, selling an estimated $2.96M.
  • GSA Capital Partners's ten largest holdings make up 3.5% of its $745M portfolio in Q1 2022.
  • GSA Capital Partners opened 631 new positions and closed 636 in Q1 2022.
  • GSA Capital Partners's portfolio value fell 6.4% quarter-over-quarter to $745M.

Based on GSA Capital Partners's 13F filing for Q1 2022, filed 11 May 2022.